Circulating regulatory (CD4+CD25+FOXP3+) T cells decrease in breast cancer patients after vaccination with an Ii-Key-modified class II HER2/neupeptide (AE37). JD Gates,LC Benavides, MG Carmichael,MT Hueman,JP Holmes, S Khoo, A Stojadinovic,E von Hofe, S Ponniah,GE PeoplesPoster Session Abstracts（2009）引用 1|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
